A Māori specific RFC1 pathogenic repeat configuration in CANVAS, likely due to a founder allele.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
01 09 2020
Historique:
received: 02 12 2019
revised: 12 04 2020
accepted: 07 05 2020
pubmed: 28 8 2020
medline: 17 2 2021
entrez: 28 8 2020
Statut: ppublish

Résumé

Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS) is a recently recognized neurodegenerative disease with onset in mid- to late adulthood. The genetic basis for a large proportion of Caucasian patients was recently shown to be the biallelic expansion of a pentanucleotide (AAGGG)n repeat in RFC1. Here, we describe the first instance of CANVAS genetic testing in New Zealand Māori and Cook Island Māori individuals. We show a novel, possibly population-specific CANVAS configuration (AAAGG)10-25(AAGGG)exp, which was the cause of CANVAS in all patients. There were no apparent phenotypic differences compared with European CANVAS patients. Presence of a common disease haplotype among this cohort suggests this novel repeat expansion configuration is a founder effect in this population, which may indicate that CANVAS will be especially prevalent in this group. Haplotype dating estimated the most recent common ancestor at ∼1430 ce. We also show the same core haplotype as previously described, supporting a single origin of the CANVAS mutation.

Identifiants

pubmed: 32851396
pii: 5897694
doi: 10.1093/brain/awaa203
pmc: PMC7526724
doi:

Substances chimiques

RFC1 protein, human 0
Replication Protein C EC 3.6.4.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2673-2680

Subventions

Organisme : Wellcome Trust
ID : 204841/Z/16/Z
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : U54 NS065712
Pays : United States
Organisme : Medical Research Council
ID : MR/T001712/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0601943
Pays : United Kingdom

Informations de copyright

© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

Ann Clin Transl Neurol. 2020 Mar;7(3):353-362
pubmed: 32153140
Am J Hum Genet. 2019 Jul 3;105(1):151-165
pubmed: 31230722
Neurology. 2011 May 31;76(22):1903-10
pubmed: 21624989
Bioinformatics. 2009 Aug 1;25(15):1961-2
pubmed: 19435744
Brain. 2020 Feb 1;143(2):480-490
pubmed: 32040566
Brain. 2014 Oct;137(Pt 10):2649-56
pubmed: 25070514
Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7676-80
pubmed: 18523023
Muscle Nerve. 2017 Jul;56(1):160-162
pubmed: 27859440
Neurology. 1998 Oct;51(4):1081-6
pubmed: 9781533
J Huntingtons Dis. 2019;8(2):171-179
pubmed: 31045518
Nat Genet. 2002 Jan;30(1):97-101
pubmed: 11731797
Nat Genet. 2019 Apr;51(4):649-658
pubmed: 30926972
Neurology. 2014 Apr 22;82(16):1410-5
pubmed: 24682971
Front Genet. 2019 Nov 22;10:1219
pubmed: 31824583
Eur J Neurol. 2018 Apr;25(4):659-665
pubmed: 29316033
Genetics. 2014 Aug;197(4):1315-27
pubmed: 24879464

Auteurs

Sarah J Beecroft (SJ)

Neurogenetic Diseases Group, Centre for Medical Research, QEII Medical Centre, University of Western Australia, Nedlands, WA 6009, Australia.
Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA 6009, Australia.

Andrea Cortese (A)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK.
Brain and Behavioural Sciences, University of Pavia, Pavia, Italy.

Roisin Sullivan (R)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK.

Wai Yan Yau (WY)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK.

Zoe Dyer (Z)

Neurology Department, Auckland City Hospital, Auckland, New Zealand.

Teddy Y Wu (TY)

Department of Neurology, Christchurch Hospital, Christchurch, New Zealand.

Eoin Mulroy (E)

Neurology Department, Auckland City Hospital, Auckland, New Zealand.

Luciana Pelosi (L)

Neurology Department, Auckland City Hospital, Auckland, New Zealand.

Miriam Rodrigues (M)

Neurology Department, Auckland City Hospital, Auckland, New Zealand.

Rachael Taylor (R)

Centre for Brain Research Neurogenetics Research Clinic, University of Auckland, Auckland, New Zealand.

Stuart Mossman (S)

Neurology Department, Wellington Hospital, Wellington, New Zealand.

Ruth Leadbetter (R)

Neurology Department, Wellington Hospital, Wellington, New Zealand.

James Cleland (J)

Neurology Department, Tauranga Hospital, Tauranga, New Zealand.

Tim Anderson (T)

Department of Neurology, Christchurch Hospital, Christchurch, New Zealand.

Gianina Ravenscroft (G)

Neurogenetic Diseases Group, Centre for Medical Research, QEII Medical Centre, University of Western Australia, Nedlands, WA 6009, Australia.
Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA 6009, Australia.

Nigel G Laing (NG)

Neurogenetic Diseases Group, Centre for Medical Research, QEII Medical Centre, University of Western Australia, Nedlands, WA 6009, Australia.
Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA 6009, Australia.

Henry Houlden (H)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK.

Mary M Reilly (MM)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, London, UK.

Richard H Roxburgh (RH)

Neurology Department, Auckland City Hospital, Auckland, New Zealand.
Centre for Brain Research Neurogenetics Research Clinic, University of Auckland, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH